Dermawan D, Alotaiq N
Sci Rep. 2025; 15(1):8896.
PMID: 40087360
DOI: 10.1038/s41598-025-93683-1.
Zhang Z, Chen C, Liu C, Sun P, Liu P, Fang S
Sci Adv. 2025; 11(10):eadq4266.
PMID: 40053593
PMC: 11887815.
DOI: 10.1126/sciadv.adq4266.
Elkayam E, Gervais F, Wu H, A Crackower M, Lieberman J
Nat Rev Immunol. 2025; .
PMID: 40044809
DOI: 10.1038/s41577-025-01142-9.
Gao C, Song J, Wang H, Shang Q, Guan X, Xu G
Acta Pharm Sin B. 2025; 15(1):349-370.
PMID: 40041908
PMC: 11873611.
DOI: 10.1016/j.apsb.2024.11.019.
Lu J, Zhou Q, Zhu D, Song H, Xie G, Zhao X
Acta Pharm Sin B. 2025; 15(1):371-391.
PMID: 40041886
PMC: 11873626.
DOI: 10.1016/j.apsb.2024.11.010.
[Latest Findings on the Role of Liquid-Liquid Phase Separation in the Regulation of Immune Cell Activation and Key Signaling].
Li J, Zhou C
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025; 55(6):1527-1532.
PMID: 39990825
PMC: 11839372.
DOI: 10.12182/20241160302.
Advance in identified targets of berberine.
Sun P, Wang Z, Ma Y, Liu Y, Xue Y, Li Y
Front Pharmacol. 2025; 16:1500511.
PMID: 39944624
PMC: 11814165.
DOI: 10.3389/fphar.2025.1500511.
Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants.
Feng S, Wierzbowski M, Hrovat-Schaale K, Dumortier A, Zhang Y, Zyulina M
Nat Immunol. 2025; 26(3):511-523.
PMID: 39930093
PMC: 11876074.
DOI: 10.1038/s41590-025-02088-9.
PRRSV-2 nsp2 Ignites NLRP3 inflammasome through IKKβ-dependent dispersed trans-Golgi network translocation.
Zhang L, Gao Y, Zhou H, Liang X, Jiang X, Gong W
PLoS Pathog. 2025; 21(1):e1012915.
PMID: 39869629
PMC: 11801707.
DOI: 10.1371/journal.ppat.1012915.
Inflammasome activation in melanoma progression: the latest update concerning pathological role and therapeutic value.
Pluetrattanabha N, Direksunthorn T, Ahmad I, Jyothi S, Shit D, Singh A
Arch Dermatol Res. 2025; 317(1):258.
PMID: 39820618
DOI: 10.1007/s00403-025-03802-1.
Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis.
Karmakar V, Chain M, Majie A, Ghosh A, Sengupta P, Dutta S
Inflammopharmacology. 2025; 33(2):461-484.
PMID: 39806051
DOI: 10.1007/s10787-024-01629-2.
O-GlcNAcylation dictates pyroptosis.
Lang Y, Li J, Zhang L
Front Immunol. 2025; 15:1513542.
PMID: 39742284
PMC: 11685218.
DOI: 10.3389/fimmu.2024.1513542.
Immunomodulation with M2 macrophage-derived extracellular vesicles for enhanced titanium implant osseointegration under diabetic conditions.
Cheng Y, Dong X, Shi J, Wu G, Tao P, Ren N
Mater Today Bio. 2025; 30:101385.
PMID: 39742145
PMC: 11683253.
DOI: 10.1016/j.mtbio.2024.101385.
Zinc homeostasis regulates caspase activity and inflammasome activation.
Gong X, Gu W, Fu S, Zou G, Jiang Z
PLoS Pathog. 2024; 20(12):e1012805.
PMID: 39689159
PMC: 11687882.
DOI: 10.1371/journal.ppat.1012805.
Run-Mu-Ling Granules Mitigate Ocular Surface Inflammatory Injury Associated with Dry Eye by Suppressing the NLRP3/GSDMD-Mediated Pyroptosis Pathway.
Luo D, Ji H, Yan X, Wang Z, Li L, Shi L
J Inflamm Res. 2024; 17:10769-10784.
PMID: 39677285
PMC: 11645896.
DOI: 10.2147/JIR.S496231.
Rosthornin B alleviates inflammatory diseases via directly targeting NLRP3.
Yang Y, Liu D, Cao H, Lu L, Zhang W, Liu C
FASEB J. 2024; 38(24):e70248.
PMID: 39673686
PMC: 11646051.
DOI: 10.1096/fj.202401198R.
Bile acid derivatives from gut microbiota promote GBPs-mediated activation of caspase-4/11 by LPS through .
Gao Y, Yue J, Ha F, Wang Y, Wang R, Yang X
Int J Biol Sci. 2024; 20(15):5831-5849.
PMID: 39664579
PMC: 11628326.
DOI: 10.7150/ijbs.97059.
Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome.
Matico R, Grauwen K, Chauhan D, Yu X, Abdiaj I, Adhikary S
EMBO Mol Med. 2024; 17(1):54-84.
PMID: 39653810
PMC: 11730736.
DOI: 10.1038/s44321-024-00181-4.
The role of the interplay between macrophage glycolytic reprogramming and NLRP3 inflammasome activation in acute lung injury/acute respiratory distress syndrome.
Luo L, Zhuang X, Fu L, Dong Z, Yi S, Wang K
Clin Transl Med. 2024; 14(12):e70098.
PMID: 39623879
PMC: 11612265.
DOI: 10.1002/ctm2.70098.
Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication.
Wang H, Wang T, Yan S, Tang J, Zhang Y, Wang L
Mol Cancer. 2024; 23(1):268.
PMID: 39614288
PMC: 11607834.
DOI: 10.1186/s12943-024-02183-9.